Agios Pharmaceuticals Inc (AGIO) SEC News Oct. 30, 2025, 10:32 UTC 3 1 comments (30% Negative) Agios Pharmaceuticals, Inc. (AGIO) Reports Q4 2025 Financial Results Comment Full text
Amneal Pharmaceuticals Inc. (AMRX) SEC News Oct. 30, 2025, 10:19 UTC 3 1 comments (30% Negative) AMNEAL PHARMACEUTICALS, INC. (AMRX) Reports Q4 2025 Financial Results Comment Full text
Integra LifeSciences Holdings (IART) SEC News Oct. 30, 2025, 10:15 UTC 3 1 comments (30% Negative) INTEGRA LIFESCIENCES HOLDINGS CORP (IART) Reports Q4 2025 Financial Results Comment Full text
Biogen Inc (BIIB) SEC News Oct. 30, 2025, 10:13 UTC 3 1 comments (10% Negative) BIOGEN INC. (BIIB) Reports Q4 2025 Financial Results Comment Full text
PetVivo Holdings Inc. (PETV) SEC News Oct. 30, 2025, 10:13 UTC 3 1 comments LOWENTHAL GARRY N 🟢 acquired 75.0K shares of PetVivo Holdings, Inc. (PETV) at $1.27 Transaction Date: Oct 23, 2025 | Filing ID: 020129 Comment Full text
Takeda Pharmaceutical Co., Ltd. (TKPHF) SEC News Oct. 30, 2025, 10:13 UTC 3 1 comments (90% Positive) Takeda Pharmaceutical Co., Ltd. (TKPHF) Reports Q4 2025 Financial Results (Form 6-K) Comment Full text
Creative Medical Technology Holdings Inc. (CELZ) SEC News Oct. 30, 2025, 10:12 UTC 3 0 comments New Form DEF 14A - CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. Filed: 2025-10-30 AccNo: 0001477932-25-007803 Size: 1 MB Comment Full text
Takeda Pharmaceutical Co., Ltd. (TKPHF) SEC News Oct. 30, 2025, 10:08 UTC 3 1 comments (10% Negative) Takeda Pharmaceutical Co., Ltd. (TKPHF) Reports Q4 2025 Financial Results (Form 6-K) Comment Full text
Wave Life Sciences (WVE) SEC News Oct. 30, 2025, 10:08 UTC 3 0 comments New Form 8-K/A - Wave Life Sciences Ltd. Filed: 2025-10-30 AccNo: 0001193125-25-257298 Size: 198 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits Comment Full text
Takeda Pharmaceutical Co., Ltd. (TKPHF) SEC News Oct. 30, 2025, 10:08 UTC 3 1 comments (10% Negative) Takeda Pharmaceutical Co., Ltd. (TKPHF) Reports Q4 2025 Financial Results (Form 6-K) Comment Full text